A

Acumen Pharmaceuticals (ABOS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.

  • 5.60
  • 5.69
  • 5.56
  • 10.97
  • -18.7%
  • --
  • 0.00
  • 132.11k
  • 229M
  • 3.02
  • -31.1%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.